CA1161032A - Cephalosporin derivatives, their production and use as antimicrobial agents - Google Patents

Cephalosporin derivatives, their production and use as antimicrobial agents

Info

Publication number
CA1161032A
CA1161032A CA000345659A CA345659A CA1161032A CA 1161032 A CA1161032 A CA 1161032A CA 000345659 A CA000345659 A CA 000345659A CA 345659 A CA345659 A CA 345659A CA 1161032 A CA1161032 A CA 1161032A
Authority
CA
Canada
Prior art keywords
formula
pyrazolyl
group
acid
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000345659A
Other languages
English (en)
French (fr)
Inventor
Helmut Hamberger
Hans Fliri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH154579A external-priority patent/CH641810A5/de
Priority claimed from CH17480A external-priority patent/CH645378A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1161032A publication Critical patent/CA1161032A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA000345659A 1979-02-16 1980-02-14 Cephalosporin derivatives, their production and use as antimicrobial agents Expired CA1161032A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1545/79 1979-02-16
CH154579A CH641810A5 (en) 1979-02-16 1979-02-16 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them
CH17480A CH645378A5 (en) 1980-01-10 1980-01-10 Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them
CH174/80 1980-01-10

Publications (1)

Publication Number Publication Date
CA1161032A true CA1161032A (en) 1984-01-24

Family

ID=25683752

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000345659A Expired CA1161032A (en) 1979-02-16 1980-02-14 Cephalosporin derivatives, their production and use as antimicrobial agents

Country Status (19)

Country Link
US (1) US4477448A (es)
AT (1) AT374806B (es)
CA (1) CA1161032A (es)
DE (1) DE3005012A1 (es)
DK (1) DK53780A (es)
ES (2) ES488651A0 (es)
FI (1) FI800381A (es)
FR (1) FR2449093A1 (es)
GB (2) GB2046734B (es)
IE (1) IE49395B1 (es)
IL (1) IL59391A (es)
IT (1) IT8047922A0 (es)
MY (1) MY8500128A (es)
NL (1) NL8000894A (es)
NZ (1) NZ192873A (es)
PH (1) PH17926A (es)
PT (1) PT70834A (es)
SE (2) SE8000982L (es)
YU (1) YU40280A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037380B1 (en) * 1980-03-28 1984-09-12 BIOCHEMIE Gesellschaft m.b.H. New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production
CH648038A5 (de) * 1981-01-19 1985-02-28 Sandoz Ag 7-((carboxymethoxyimino)-1h-pyrazol-3-yl-acetyl)amino-3-desacetoxy-3-(1-methyl-1h-tetrazol-5-yl-thio)cephalosporansaeure und salze, verfahren zur herstellung und verwendung.
GB2125033B (en) * 1982-07-23 1985-08-29 Servipharm Ltd Cephalosporins
US4698338A (en) * 1986-02-19 1987-10-06 Eli Lilly And Company 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins
US5688964A (en) * 1996-02-13 1997-11-18 Eastman Kodak Company Process for preparing a acylhyrazino pyrazole derivative
KR100770419B1 (ko) * 1999-09-24 2007-10-26 니혼노야쿠가부시키가이샤 살충, 살진드기제
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins

Also Published As

Publication number Publication date
FR2449093B1 (es) 1983-07-29
ES8203848A1 (es) 1982-04-01
PH17926A (en) 1985-01-31
SE8500589D0 (sv) 1985-02-08
IE49395B1 (en) 1985-10-02
SE8000982L (sv) 1980-08-17
GB2046734B (en) 1983-09-01
US4477448A (en) 1984-10-16
GB8309730D0 (en) 1983-05-18
FI800381A (fi) 1980-08-17
ES8102134A1 (es) 1980-12-16
NL8000894A (nl) 1980-08-19
DE3005012A1 (de) 1980-11-27
IL59391A0 (en) 1980-05-30
ATA78780A (de) 1983-10-15
YU40280A (en) 1983-06-30
IL59391A (en) 1983-05-15
ES497002A0 (es) 1982-04-01
PT70834A (en) 1980-03-01
AT374806B (de) 1984-06-12
FR2449093A1 (fr) 1980-09-12
IE800284L (en) 1980-08-16
ES488651A0 (es) 1980-12-16
GB2046734A (en) 1980-11-19
GB2117774B (en) 1984-03-21
NZ192873A (en) 1984-07-31
MY8500128A (en) 1985-12-31
GB2117774A (en) 1983-10-19
IT8047922A0 (it) 1980-02-15
DK53780A (da) 1980-08-17

Similar Documents

Publication Publication Date Title
US4264595A (en) 7-[2-(2-Imino-4-thiazolin-4-yl)-2-(syn)-hydroxy-iminoacetamido]-cephalosporins
CA1161032A (en) Cephalosporin derivatives, their production and use as antimicrobial agents
JPH0255437B2 (es)
JPH0313237B2 (es)
CA1120923A (en) Cephalosporanic acid derivatives and processes for the preparation thereof
PL85513B1 (es)
CA1103237A (en) Unsaturated derivatives of 7-acylamido-3-cephem-4- carboxylic acid and process for their preparation
US4048311A (en) 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl)cephalosporins
NZ245200A (en) Cephalosporin derivatives, medicaments and intermediate compounds
US3907786A (en) 7-{8 {60 -(2-aminomethyl-1,4-cyclohexadienyl)acetamido{9 -3-heterocyclic-thiomethyl-3-cephem-4-carboxylic acids and salts
US4609654A (en) Derivatives of cephalosporins substituted in 3 position by a thiomethyl heterocycle group; and pharmaceutical compositions containing them
SE444682B (sv) Nya 7alfa-metoxicefalosporiner
US4140694A (en) Intermediates for preparing 7-acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolylthiomethyl)cephalosporins
CA1185598A (en) 7-¬(carboxymethoxyimino)-1h-pyrazol-3-yl-acetyl| amino-3-desacetoxy-3-(1-methyl-1h-tetrazol-5-yl- thio) cephalosporanic acid
US4159373A (en) 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl) cephalosporins
US4311699A (en) Aminoacid derivatives of cephalosporin compounds
US3996216A (en) 3-Heterothio derivatives of (formylamino)acetylamino-7-alpha-methoxy cephalosporins
IE45392B1 (en) Cephalosporin compounds
AT378371B (de) Verfahren zur herstellung neuer cephalosporin -derivate
US4092480A (en) Intermediates for preparing substituted phenylglycylcephalosporins
US5484928A (en) 2-(2-aminothiazol-4-yl)-2-oxoacetic acid derivatives
CA1064019A (en) Cepham derivatives and preparation thereof
US4044047A (en) Intermediates for preparing substituted phenylglycylcephalosporins
US4404376A (en) Cephalosporanic acid derivatives
CA1146553A (en) Intermediates for cephalosporanic acid derivatives and processes for their preparation

Legal Events

Date Code Title Description
MKEX Expiry